Breaking News

  • 22 hours ago

  • Pharma Now Editorial Team

Akums Launches DCGI-Approved Triple-Action Combination Therapy for Diabetic Peripheral Neuropathic Pain
Breaking News

More News

Evommune Reports Phase 2b Failure for EVO756 in Chronic Spontaneous Urticaria at 12 Weeks

Evommune Reports Phase 2b Failure for EVO756 in Chronic Spontaneous Ur...

Pharma Now Editorial Team

Ad
Advertisement

Interviews & Opinions

Article

Dr Santosh Indraksha topped UPSC, left J&J's global postings, and joined CDSCO. On Schedule M, 295 medicines during COVID-19, QR codes, and why AI mus...

FT - Dr Santosh Indraksha

Read More

Article
From ₹250 a Month to Building Encube Ethicals: Mehul Shah on Entrepreneurship, Culture, Quality, and Pharma Leadership

FT - Mr. Mehul Shah

Magazine Cover
May-June 2026 Edition Issue

The New Kings of Pharma From Molecules to Meaning

Cover StoryData Nationalism: Who Owns the Patient Genome? and the future of healthcare data ownership.

Pharma News – Global updates on drug approvals, AI partnerships, clinical trials, and industry developments.

In Talks with Leadership – Conversations with Vikram Shukla and Prashant Menon.

Startup Story – Featuring KVault and its approach to secure data protection and digital trust.

Market Insights & Commercial Lens – Trust in pharma, compliance, commercial impact, and modern marketing challenges.

Ad
Advertisement
Ad